Abbott Laboratories Corporation

Thomas Barton May

Earl R Speicher

John M Hofstetter

Lukchiu Li

John Paul Oberdier

Edward Anthony Pec

James R Waterson

Lawrence John Rhodes

Kathee Jantzi

Clayton S Ovenshire

Bernard A Mikrut

Sukumaran K Menon

Kathleen L Olson

Dennis A Stephens

Daniel H Robinson

Stable pharmaceutical formulations of a therapeutic agent, a low molecular weight alcohol and a glycol derivative are disclosed. Preferred formulations include 19-nor-1&agr;,3&bgr;,25-trihydroxy-9,10-secoergosta-5,7(E),22(E)-triene.

Cosolvent formulations

The present invention is directed to a sterile pharmaceutical composition comprising a propofol containing oil-in-water emulsion formulation having as an antimicrobial agent, a member selected from the group consisting of benzyl alcohol and ethylene diamine tetra acetic acid; benzethonium chloride; and benzyl alcohol and sodium benzoate.

Propofol composition

The present invention is directed to a sterile pharmaceutical composition comprising a propofol containing oil-in-water emulsion formulation having as an antimicrobial agent, a member selected from the group consisting of benzyl alcohol and sodium ethylene diamine tetraacetate; benzethonium chloride; and benzyl alcohol and sodium benzoate.

Stable pharmaceutical formulations of a therapeutic agent, a low molecular weight alcohol and a glycol derivative are disclosed. Preferred formulations include 19-nor-1.alpha.,3.beta.,25-trihydroxy-9,10-secoergosta-5,7(E),22(E)-triene .

Growing community of inventors

Grayslake, IL, United States of America

Thomas Barton May